Matches in SemOpenAlex for { <https://semopenalex.org/work/W1520754465> ?p ?o ?g. }
- W1520754465 endingPage "e0131861" @default.
- W1520754465 startingPage "e0131861" @default.
- W1520754465 abstract "Glutamate carboxypeptidase II (GCP-II) is a brain metallopeptidase that hydrolyzes the abundant neuropeptide N-acetyl-aspartyl-glutamate (NAAG) to NAA and glutamate. Small molecule GCP-II inhibitors increase brain NAAG, which activates mGluR3, decreases glutamate, and provide therapeutic utility in a variety of preclinical models of neurodegenerative diseases wherein excess glutamate is presumed pathogenic. Unfortunately no GCP-II inhibitor has advanced clinically, largely due to their highly polar nature resulting in insufficient oral bioavailability and limited brain penetration. Herein we report a non-invasive route for delivery of GCP-II inhibitors to the brain via intranasal (i.n.) administration. Three structurally distinct classes of GCP-II inhibitors were evaluated including DCMC (urea-based), 2-MPPA (thiol-based) and 2-PMPA (phosphonate-based). While all showed some brain penetration following i.n. administration, 2-PMPA exhibited the highest levels and was chosen for further evaluation. Compared to intraperitoneal (i.p.) administration, equivalent doses of i.n. administered 2-PMPA resulted in similar plasma exposures (AUC0-t, i.n./AUC0-t, i.p. = 1.0) but dramatically enhanced brain exposures in the olfactory bulb (AUC0-t, i.n./AUC0-t, i.p. = 67), cortex (AUC0-t, i.n./AUC0-t, i.p. = 46) and cerebellum (AUC0-t, i.n./AUC0-t, i.p. = 6.3). Following i.n. administration, the brain tissue to plasma ratio based on AUC0-t in the olfactory bulb, cortex, and cerebellum were 1.49, 0.71 and 0.10, respectively, compared to an i.p. brain tissue to plasma ratio of less than 0.02 in all areas. Furthermore, i.n. administration of 2-PMPA resulted in complete inhibition of brain GCP-II enzymatic activity ex-vivo confirming target engagement. Lastly, because the rodent nasal system is not similar to humans, we evaluated i.n. 2-PMPA also in a non-human primate. We report that i.n. 2-PMPA provides selective brain delivery with micromolar concentrations. These studies support intranasal delivery of 2-PMPA to deliver therapeutic concentrations in the brain and may facilitate its clinical development." @default.
- W1520754465 created "2016-06-24" @default.
- W1520754465 creator A5013531845 @default.
- W1520754465 creator A5021315052 @default.
- W1520754465 creator A5023686004 @default.
- W1520754465 creator A5041458028 @default.
- W1520754465 creator A5051175845 @default.
- W1520754465 creator A5056312293 @default.
- W1520754465 creator A5069018183 @default.
- W1520754465 creator A5078466007 @default.
- W1520754465 creator A5089972107 @default.
- W1520754465 creator A5090359406 @default.
- W1520754465 date "2015-07-07" @default.
- W1520754465 modified "2023-10-05" @default.
- W1520754465 title "Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration" @default.
- W1520754465 cites W1483485226 @default.
- W1520754465 cites W1486910148 @default.
- W1520754465 cites W1500510737 @default.
- W1520754465 cites W1528907365 @default.
- W1520754465 cites W1543959669 @default.
- W1520754465 cites W1964238705 @default.
- W1520754465 cites W1964271667 @default.
- W1520754465 cites W1964435351 @default.
- W1520754465 cites W1969074641 @default.
- W1520754465 cites W1969953999 @default.
- W1520754465 cites W1974294719 @default.
- W1520754465 cites W1978430524 @default.
- W1520754465 cites W1979196482 @default.
- W1520754465 cites W1980612042 @default.
- W1520754465 cites W1983998585 @default.
- W1520754465 cites W1984950849 @default.
- W1520754465 cites W1986834491 @default.
- W1520754465 cites W1987567565 @default.
- W1520754465 cites W1989208232 @default.
- W1520754465 cites W1998784857 @default.
- W1520754465 cites W2001525797 @default.
- W1520754465 cites W2001773630 @default.
- W1520754465 cites W2003021017 @default.
- W1520754465 cites W2003656892 @default.
- W1520754465 cites W2008873564 @default.
- W1520754465 cites W2010392115 @default.
- W1520754465 cites W2018340655 @default.
- W1520754465 cites W2019363362 @default.
- W1520754465 cites W2021814641 @default.
- W1520754465 cites W2028669320 @default.
- W1520754465 cites W2036574824 @default.
- W1520754465 cites W2036794860 @default.
- W1520754465 cites W2041302042 @default.
- W1520754465 cites W2043509263 @default.
- W1520754465 cites W2043566883 @default.
- W1520754465 cites W2044682044 @default.
- W1520754465 cites W2046132587 @default.
- W1520754465 cites W2050416880 @default.
- W1520754465 cites W2054046368 @default.
- W1520754465 cites W2054349797 @default.
- W1520754465 cites W2066734010 @default.
- W1520754465 cites W2072491947 @default.
- W1520754465 cites W2072692763 @default.
- W1520754465 cites W2072934836 @default.
- W1520754465 cites W2077756131 @default.
- W1520754465 cites W2081758723 @default.
- W1520754465 cites W2081986155 @default.
- W1520754465 cites W2082171751 @default.
- W1520754465 cites W2095383832 @default.
- W1520754465 cites W2103515806 @default.
- W1520754465 cites W2107405263 @default.
- W1520754465 cites W2107870182 @default.
- W1520754465 cites W2110344582 @default.
- W1520754465 cites W2114462462 @default.
- W1520754465 cites W2117497657 @default.
- W1520754465 cites W2118321313 @default.
- W1520754465 cites W2123932686 @default.
- W1520754465 cites W2124092054 @default.
- W1520754465 cites W2136073863 @default.
- W1520754465 cites W2136859392 @default.
- W1520754465 cites W2139505125 @default.
- W1520754465 cites W2150083064 @default.
- W1520754465 cites W2153284686 @default.
- W1520754465 cites W2160034345 @default.
- W1520754465 cites W2162346026 @default.
- W1520754465 cites W2167224636 @default.
- W1520754465 cites W2168732876 @default.
- W1520754465 cites W2169789482 @default.
- W1520754465 cites W2171637628 @default.
- W1520754465 cites W2328560698 @default.
- W1520754465 cites W2590969654 @default.
- W1520754465 doi "https://doi.org/10.1371/journal.pone.0131861" @default.
- W1520754465 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4494705" @default.
- W1520754465 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26151906" @default.
- W1520754465 hasPublicationYear "2015" @default.
- W1520754465 type Work @default.
- W1520754465 sameAs 1520754465 @default.
- W1520754465 citedByCount "25" @default.
- W1520754465 countsByYear W15207544652016 @default.
- W1520754465 countsByYear W15207544652017 @default.
- W1520754465 countsByYear W15207544652018 @default.
- W1520754465 countsByYear W15207544652019 @default.
- W1520754465 countsByYear W15207544652020 @default.